Photo from wikipedia
Calcific aortic valve stenosis (AS) is the most prevalent valvular heart disease in high-income countries [(1)][1], and currently there is no pharmacotherapy known to prevent its progression. Oral anticoagulants are… Click to show full abstract
Calcific aortic valve stenosis (AS) is the most prevalent valvular heart disease in high-income countries [(1)][1], and currently there is no pharmacotherapy known to prevent its progression. Oral anticoagulants are the benchmark for preventing thromboembolic complications, especially in condition
Keywords:
progression;
valve stenosis;
aortic valve;
calcific aortic
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!